309 related articles for article (PubMed ID: 20046070)
1. Preparation of orally disintegrating tablets with taste-masking function: masking effect in granules prepared with correctives using the dry granulation method and evaluation of tablets prepared using the taste-masked granules.
Kawano Y; Ito A; Sasatsu M; Machida Y
Yakugaku Zasshi; 2010 Jan; 130(1):81-6. PubMed ID: 20046070
[TBL] [Abstract][Full Text] [Related]
2. [Preparation and evaluation of taste masked orally disintegrating tablets with granules made by the wet granulation method].
Kawano Y; Ito A; Sasatsu M; Machida Y; Onishi H
Yakugaku Zasshi; 2010 Dec; 130(12):1737-42. PubMed ID: 21139401
[TBL] [Abstract][Full Text] [Related]
3. [Preparation of orally disintegrating tablets for masking of unpleasant taste: comparison with corrective-adding methods].
Kawano Y; Ito A; Sasatsu M; Machida Y
Yakugaku Zasshi; 2010 Jan; 130(1):75-80. PubMed ID: 20046069
[TBL] [Abstract][Full Text] [Related]
4. Preparation and evaluation of tablets rapidly disintegrating in saliva containing bitter-taste-masked granules by the compression method.
Ishikawa T; Watanabe Y; Utoguchi N; Matsumoto M
Chem Pharm Bull (Tokyo); 1999 Oct; 47(10):1451-4. PubMed ID: 10553641
[TBL] [Abstract][Full Text] [Related]
5. A novel and discriminative method of in vitro disintegration time for preparation and optimization of taste-masked orally disintegrating tablets of carbinoxamine maleate.
Liu Y; Li P; Qian R; Sun T; Fang F; Wang Z; Ke X; Xu B
Drug Dev Ind Pharm; 2018 Aug; 44(8):1317-1327. PubMed ID: 29521132
[TBL] [Abstract][Full Text] [Related]
6. Preparation and evaluation of unpleasant taste-masked pioglitazone orally disintegrating tablets.
Nakano Y; Maeda A; Uchida S; Namiki N
Int J Pharm; 2013 Mar; 446(1-2):160-5. PubMed ID: 23419665
[TBL] [Abstract][Full Text] [Related]
7. Further improvement of orally disintegrating tablets using micronized ethylcellulose.
Okuda Y; Irisawa Y; Okimoto K; Osawa T; Yamashita S
Int J Pharm; 2012 Feb; 423(2):351-9. PubMed ID: 22138608
[TBL] [Abstract][Full Text] [Related]
8. Application of a quality-by-design approach for utilizing sodium stearyl fumarate as a taste-masking agent in dextromethorphan hydrobromide orally disintegrating tablets.
Mahrous GM; Ibrahim MA; Mostafa HF; Elzayat EM
Pharm Dev Technol; 2019 Jul; 24(6):711-719. PubMed ID: 30714850
[TBL] [Abstract][Full Text] [Related]
9. Preparation and evaluation of orally rapidly disintegrating tablets containing taste-masked particles using one-step dry-coated tablets technology.
Kondo K; Niwa T; Ozeki Y; Ando M; Danjo K
Chem Pharm Bull (Tokyo); 2011; 59(10):1214-20. PubMed ID: 21963629
[TBL] [Abstract][Full Text] [Related]
10. Preparation and evaluation of swelling induced-orally disintegrating tablets by microwave irradiation.
Sano S; Iwao Y; Kimura S; Itai S
Int J Pharm; 2011 Sep; 416(1):252-9. PubMed ID: 21763765
[TBL] [Abstract][Full Text] [Related]
11. Combination effect of physical and gustatory taste masking for propiverine hydrochloride orally disintegrating tablets on palatability.
Matsui R; Uchida S; Namiki N
Biol Pharm Bull; 2015; 38(1):17-22. PubMed ID: 25744453
[TBL] [Abstract][Full Text] [Related]
12. Formulation, preparation, and evaluation of novel orally disintegrating tablets containing taste-masked naproxen sodium granules and naratriptan hydrochloride.
Stange U; Führling C; Gieseler H
J Pharm Sci; 2014 Apr; 103(4):1233-45. PubMed ID: 24532095
[TBL] [Abstract][Full Text] [Related]
13. Optimized furosemide taste masked orally disintegrating tablets.
Ibrahim MA; Abou El Ela AESF
Saudi Pharm J; 2017 Nov; 25(7):1055-1062. PubMed ID: 29158715
[TBL] [Abstract][Full Text] [Related]
14. Microwave-Assisted Development of Orally Disintegrating Tablets by Direct Compression.
Kande KV; Kotak DJ; Degani MS; Kirsanov D; Legin A; Devarajan PV
AAPS PharmSciTech; 2017 Aug; 18(6):2055-2066. PubMed ID: 27995465
[TBL] [Abstract][Full Text] [Related]
15. Formulation and evaluation of meloxicam oral disintegrating tablet with dissolution enhanced by combination of cyclodextrin and ion exchange resins.
Samprasit W; Akkaramongkolporn P; Ngawhirunpat T; Rojanarata T; Opanasopit P
Drug Dev Ind Pharm; 2015 Jun; 41(6):1006-16. PubMed ID: 24865111
[TBL] [Abstract][Full Text] [Related]
16. Tablet characteristics and pharmacokinetics of orally disintegrating tablets containing coenzyme Q10 granules prepared by different methods.
Kashiwagura Y; Takusagawa S; Ikematsu Y; Tanaka S; Namiki N; Uchida S
Acta Pharm; 2023 Mar; 73(1):107-119. PubMed ID: 36692467
[TBL] [Abstract][Full Text] [Related]
17. Formulation and optimization of orally disintegrating tablets of sumatriptan succinate.
Sheshala R; Khan N; Darwis Y
Chem Pharm Bull (Tokyo); 2011; 59(8):920-8. PubMed ID: 21804234
[TBL] [Abstract][Full Text] [Related]
18. Rapidly disintegrating tablets containing taste masked metoclopramide hydrochloride prepared by extrusion-precipitation method.
Randale SA; Dabhi CS; Tekade AR; Belgamwar VS; Gattani SG; Surana SJ
Chem Pharm Bull (Tokyo); 2010 Apr; 58(4):443-8. PubMed ID: 20410620
[TBL] [Abstract][Full Text] [Related]
19. Formulation and evaluation of taste-masked levocetirizine dihydrochloride orally disintegrating tablets.
Devireddy SR; Gonugunta CS; Veerareddy PR
PDA J Pharm Sci Technol; 2009; 63(6):521-6. PubMed ID: 20169858
[TBL] [Abstract][Full Text] [Related]
20. Formulation and in vivo evaluation of ondansetron orally disintegrating tablets using different superdisintegrants.
Sheshala R; Khan N; Chitneni M; Darwis Y
Arch Pharm Res; 2011 Nov; 34(11):1945-56. PubMed ID: 22139694
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
